CONGRESS|#EHA2021|Nikhil C Munshi, highlighted various emerging BCMA targeting CART cell therapies in MM e.g. ide-cel, cilta-cel, P-BCMA & ALLO-715. KarMMa study for Ide-cel results were discussed #mmsm, #myeloma, @harvardmed, @DanaFarber pic.twitter.com/2lhgUfo95r

— Multiple Myeloma Hub (@MM_Hub) June 12, 2021